Replek Farm LTD is a pharmaceutical manufacturer that specializes in generic finished dosage forms. Founded in 2001 as a daughter company of REPLEK AD Shareholding Company, it has a rich history in the healthcare sector. The company is equipped with state-of-the-art technology and facilities, adhering to Good Manufacturing Practice (GMP) standards. With a focus on producing medicinal non-sterile products for human use, including solid forms, semi-solid and liquid pharmaceutical forms, as well as packaging, batch certification, food supplements, and cosmetics.
Replek Farm's business goals and objectives revolve around increasing their annual turnover by 20-30% through cost-effective production and competitive pricing. They aim to capture a significant share of the market expenditure for selected products, both domestically and internationally, over the next five years.
As a venture capital firm, investing in Replek Farm could prove to be a lucrative opportunity in the pharmaceutical industry. The company's strong foundation, adherence to quality standards, and ambitious growth targets make it an attractive prospect for investors seeking long-term potential and stability within the pharmaceutical sector.
